α1-Antitrypsin Deficiency in Childhood

Jeffrey H. Teckman

doi:10.1055/s-2007-985072

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2007; 27(3): 274-281
DOI: 10.1055/s-2007-985072

α₁-Antitrypsin Deficiency in Childhood

Jeffrey H. Teckman¹

¹Department of Pediatrics, St. Louis University, Cardinal Glennon Children's Medical Center, St. Louis, Missouri

Abstract

ABSTRACT

α₁-Antitrypsin deficiency is a common genetic disease in which individuals homozygous for the mutant Z allele are at risk for the development of liver disease and emphysema. The mutant Z protein product is synthesized in hepatocytes but then accumulates intracellularly rather then being appropriately secreted. The effects of the intracellular accumulation of the mutant Z protein in the liver include the formation of protein polymers, activation of autophagy, mitochondrial injury, and caspase activation, which progress in a cascade causing hepatocellular injury. Liver disease can occur at any age, although the majority of children are free of significant liver dysfunction. The variable clinical presentations suggest an important contribution of genetic and environmental disease modifiers. The heterozygous carrier state for the mutant Z gene, present in 1.5% to 3% of the population, is not itself a common cause of liver injury but may be a modifier gene for other liver diseases.

KEYWORDS

α₁-Antitrypsin - autophagy - apoptosis

Full Text

References

REFERENCES

1 Teckman J H, Lindblad D. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management. Curr Gastroenterol Rep. 2006; 8 14-20
2 Rudnick D A, Liao Y, An J K, Muglia L J, Perlmutter D H, Teckman J H. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology. 2004; 39 1048-1055
3 American Thoracic Society/European Respiratory Society Statement . Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003; 168 818-900
4 Qu D, Teckman J H, Perlmutter D H. Review: alpha 1-antitrypsin deficiency associated liver disease. J Gastroenterol Hepatol. 1997; 12 404-416
5 Eriksson S. Discovery of alpha 1-antitrypsin deficiency. Lung. 1990; 168(suppl) 523-529
6 Eriksson S. Alpha 1-antitrypsin deficiency. J Hepatol. 1999; 30(suppl 1) 34-39
7 Eriksson S. A 30-year perspective on alpha 1-antitrypsin deficiency. Chest. 1996; 110(suppl) 237S-242S
8 Perlmutter D H. Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis. 2004; 8 839-859
9 Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976; 294 1316-1321
10 Sveger T. Alpha 1-antitrypsin deficiency in early childhood. Pediatrics. 1978; 62 22-25
11 An J K, Blomenkamp K, Lindblad D, Teckman J H. Quantitative isolation of alphalAT mutant Z protein polymers from human and mouse livers and the effect of heat. Hepatology. 2005; 41 160-167
12 Sveger T, Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology. 1995; 22 514-517
13 Sveger T. The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand. 1988; 77 847-851
14 Mowat A P. Alpha 1-antitrypsin deficiency (PiZZ): features of liver involvement in childhood. Acta Paediatr Suppl. 1994; 393 13-17
15 Pittschieler K, Massi G. Alpha 1 antitrypsin deficiency in two population groups in north Italy. Padiatr Padol. 1988; 23 307-311
16 Eriksson S. Alpha-1-antitrypsin deficiency: natural course and therapeutic strategies. In: Boyer JL, Blum HE, Maier K-P, Sauerbruch T, Stalder GA Falk Symposium 115: Liver Cirrhosis and Its Development. Dordrecht; Kluwer Academic Publishers 2001: 307-315
17 Sveger T, Piitulainen E, Arborelius Jr M. Lung function in adolescents with alpha 1-antitrypsin deficiency. Acta Paediatr. 1994; 83 1170-1173
18 Eden E, Hammel J, Rouhani F N et al.. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest. 2003; 123 765-771
19 Lomas D A, Finch J T, Seyama K, Nukiwa T, Carrell R W. Alpha 1-antitrypsin Siiyama (Ser53→Phe): further evidence for intracellular loop-sheet polymerization. J Biol Chem. 1993; 268 15333-15335
20 Lomas D A, Elliott P R, Sidhar S K et al.. Alpha 1-antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerization. J Biol Chem. 1995; 270 16864-16870
21 Laurell C B, Sveger T. Mass screening of newborn Swedish infants for alpha antitrypsin deficiency. Am J Hum Genet. 1975; 27 213-217
22 Sveger T, Thelin T, McNeil T F. Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition. Acta Paediatr. 1997; 86 37-40
23 McNeil T F, Sveger T, Thelin T. Psychosocial effects of screening for somatic risk: the Swedish alpha 1 antitrypsin experience. Thorax. 1988; 43 505-507
24 Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax. 2002; 57 705-708
25 Teckman J H. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J Pediatr Gastroenterol Nutr. 2004; 39 34-37
26 Duan Y Y, Wu J, Zhu J L et al.. Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology. 2004; 127 1222-1232
27 Lomas D A, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest. 2002; 110 1585-1590
28 Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter D H. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci USA. 1994; 91 9014-9018
29 Qu D, Teckman J H, Omura S, Perlmutter D H. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem. 1996; 271 22791-22795
30 Dafforn T R, Mahadeva R, Elliott P R, Sivasothy P, Lomas D A. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem. 1999; 274 9548-9555
31 Lomas D A, Evans D L, Finch J T, Carrell R W. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature. 1992; 357 605-607
32 Cabral C M, Choudhury P, Liu Y, Sifers R N. Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem. 2000; 275 25015-25022
33 Teckman J H, Burrows J, Hidvegi T, Schmidt B, Hale P D, Perlmutter D H. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem. 2001; 276 44865-44872
34 Teckman J H, Perlmutter D H. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol. 2000; 279 G961-G974
35 Sifers R N. Cell biology: protein degradation unlocked. Science. 2003; 299 1330-1331
36 Lomas D A, Parfrey H. Alpha1-antitrypsin deficiency. 4: molecular pathophysiology. Thorax. 2004; 59 529-535
37 Perlmutter D H. Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Methods Mol Biol. 2003; 232 39-56
38 Lomas D A, Evans D L, Stone S R, Chang W S, Carrell R W. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry. 1993; 32 500-508
39 Lin L, Schmidt B, Teckman J, Perlmutter D H. A naturally occurring nonpolymerogenic mutant of alpha 1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum. J Biol Chem. 2001; 276 33893-33898
40 Wu Y, Swulius M T, Moremen K W, Sifers R N. Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc Natl Acad Sci USA. 2003; 100 8229-8234
41 Lawless M W, Greene C M, Mulgrew A, Taggart C C, O'Neill S J, McElvaney N G. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol. 2004; 172 5722-5726
42 Teckman J H, An J K, Blomenkamp K, Schmidt B, Perlmutter D. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol. 2004; 286 G851-G862
43 Teckman J H, An J K, Loethen S, Perlmutter D H. Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy. Am J Physiol Gastrointest Liver Physiol. 2002; 283 G1156-G1165
44 Teckman J H, Perlmutter D H. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem. 1996; 271 13215-13220
45 Marcus N Y, Perlmutter D H. Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z. J Biol Chem. 2000; 275 1987-1992
46 Rudnick D A, Shikapwashya O, Blomenkamp K, Teckman J H. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency. Hepatology. 2006; 44 976-982
47 Pittschieler K. Liver disease and heterozygous alpha-1-antitrypsin deficiency. Acta Paediatr Scand. 1991; 80 323-327
48 Kaserbacher R, Propst T, Propst A, Graziadei I, Judmaier G, Vogel W. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1993; 18 707-708
49 Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med. 1992; 117 641-645
50 Mahadeva R, Chang W S, Dafforn T R et al.. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest. 1999; 103 999-1006

Jeffrey H TeckmanM.D.

Department of Pediatrics, St. Louis University, Cardinal Glennon Children's Medical Center

1465 South Grand Blvd., St. Louis, MO 63104